Abivax SA Sponsored ADR share price logo

Abivax SA Sponsored ADR

NASDAQ: ABVX

Mid Cap

$86.59

-2.47

(-2.77%)

as on

Abivax SA Sponsored ADR Stock Performance

as on October 31, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $85.81
    $88.80
    downward going graph

    0.90%

    Downside

    2.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $69.81
    $148.83
    downward going graph

    19.38%

    Downside

    71.88%

    Upside

    downward going graph

Abivax SA Sponsored ADR share price movements today

Previous Close
$89.06
Open
$87.72
Volume
707.0K
Market Cap
$7.6B
Day's Low - High
$85.81 - $88.80
52 Week Low - High
$69.81 - $148.83

Abivax SA Sponsored ADR Historical Returns

1 Month Return
-6.77 %
3 Month Return
-30.68 %
1 Year Return
-15.46 %
3 Year Return
+ 783.57 %
5 Year Return
0 %

Abivax SA Sponsored ADR Stock Fundamentals & Key Indicators

Check Abivax SA Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.6B

EPS (TTM)

-3.57

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-16.78

Industry PE ratio

-7.37

PEG Ratio

0.30

EBITDA

-378.9M

Revenue (TTM)

-

Profit Margin

153.15%

Return On Equity TTM

-85.88%

Abivax SA Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abivax SA Sponsored ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Abivax SA Sponsored ADR image
Abivax SA Sponsored ADR
StrongBuy$7.6BNA-16.78153.15%0.00%
Moderna image
Moderna
Neutral$88.5B-36.40%-27.78-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B208.09%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B45.26%19.7685.77%0.40%

Stock Returns calculator for Abivax SA Sponsored ADR Stock including INR - Dollar returns

The Abivax SA Sponsored ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Abivax SA Sponsored ADR investment value today

Current value as on today

₹90,477

Returns

-₹9,523

(-9.52%)

Returns from Abivax SA Sponsored ADR Stock

-₹15,456 (-15.46%)

Dollar Impact

₹5,933 (+5.93%)

Analyst Recommendation on Abivax SA Sponsored ADR Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71428571428571% of analysts recommend a 'BUY' rating for Abivax SA Sponsored ADR. Average target price of $163.58

Abivax SA Sponsored ADR Share Price Target

Get share price movements and forecasts by analysts on Abivax SA Sponsored ADR.

What analysts predicted

47.07%UPSIDE

Target Price

$163.58

Current Price

$86.59

Analyzed by

7 Analysts

High

$175

Target

$163.58

Low

$118

Abivax SA Sponsored ADR target price $163.58, a slight upside of 47.07% compared to current price of $86.59. According to 7 analysts rating.

Indian Investors' Interest in Abivax SA Sponsored ADR Stock

Investment in Abivax SA Sponsored ADR Shares on INDmoney has grown by 462.50% in the last 30 days, indicating increased investment activity.

Time period: to

Change:462.50% versus previous 30 day period

Search interest for Abivax SA Sponsored ADR Stock has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-69% versus previous 30 day period

Abivax SA Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Mar 2024
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Total Revenue
-
2
2
2
2
-
-
-
-
-
Gross Profit
0
2
2
2
2
-
-
-
-
-
Operating Income
-25
-18
-38
-39
-92
-35
-47
-46
-199
-84
EBITDA
-25
-15
-36
-39
-92
-34
-47
-44
-256
-122
Interest Expense
2
2
1
14
5
3
4
3
15
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-27
-31
-42
-54
-98
-38
-52
-48
-281
-123
Income Tax Expense
-2
-2
-2
-2
-2
-
-
-
5
-6
Net Income
-24
-29
-40
-51
-95
-38
-52
-48
-287
-117
Net Profit Margin
0.00%
100.00%
100.00%
100.00%
100.00%
100.00%
0.00%
0.00%
0.00%
0.00%

Abivax SA Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
-
-
-
-
-
Gross Profit
-14
-15
-28
-33
-45
-50
-
-
-
Operating Income
-14
-19
-33
-38
-41
-64
-127
-172
-246
EBITDA
-13
-19
-33
-37
-38
-53
-133
-162
-300
Interest Expense
-
0
1
2
3
6
13
12
28
Depreciation
0
0
0
0
0
0
0
1
1
Income Before Tax
-14
-19
-34
-40
-42
-60
-147
-176
-330
Income Tax Expense
-2
-3
-4
-2
-
-
-
-
5
Net Income
-11
-15
-30
-37
-42
-60
-147
-176
-336
Net Profit Margin
-60.00%
-277.78%
-1409300.00%
-53601.59%
-321.62%
97.60%
98.98%
0.00%
0.00%

Abivax SA Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Mar 2024
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Net Income
-24
-21
-40
-51
-95
-38
-52
-48
-222
-117
Operating Cash Flow
-21
-25
-39
-27
-71
-50
-33
-33
-71
-51
Investing Cash Flow
-1
-3
0
-1
-8
11
1
0
3
1
Financing Cash Flow
79
-6
40
117
222
19
-7
-8
603
-39
Change in Cash
56
-34
0
87
137
-19
-40
-42
528
-89

Abivax SA Sponsored ADR Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
-14
-19
-33
-38
-42
-60
-147
-176
-322
Operating Cash Flow
-8
-14
-27
-29
-45
-53
-100
-154
-155
Investing Cash Flow
0
0
0
0
-6
-12
-10
15
-13
Financing Cash Flow
2
10
24
49
82
32
340
28
531
Change in Cash
-5
-4
-3
19
31
-33
224
-107
389

Global Institutional Holdings in Abivax SA Sponsored ADR

Check out the Institutions with significant holdings in Abivax SA Sponsored ADR.

Funds
Holdings
Paul McLernon
3.18%
Peter Kolchinsky
1.29%
ALGER INSTITUTIONAL FUNDS
1.01%
Felix Baker
1.00%
iShares
0.76%
See all

Abivax SA Sponsored ADR News & Key Events

  • img

    Today's Timeline - 21 September

    Mon, 10:35 PM

    -

    Abivax options imply a 6.0% move in share price post-earnings, with calls leading puts.

    Tue, 01:40 AM

    -

    Abivax appoints Chris Rabbat as Chief Medical Officer, succeeding Fabio Cataldi, effective immediately.

Insights on Abivax SA Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ABVX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, ABVX stock has moved up by 808.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 733.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -48.46M → -117.43M (in $), with an average decrease of 142.3% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 7.39M → -2.01M (in $), with an average decrease of 136.4% per quarter

About Abivax SA Sponsored ADR

Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases. A cornerstone of their product pipeline is ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's Disease, and COVID-19. This compound is also being evaluated in Phase IIa studies for rheumatoid arthritis and has successfully completed Phase IIa trials demonstrating viral remission in patients with HIV. Additionally, the company is advancing ABX 196, an immune-boosting candidate, through Phase 1/2 clinical trials targeting hepatocellular cancer. Abivax also conducts research initiatives for conditions like Dengue fever, influenza, and respiratory syncytial virus. The company has secured license agreements with key French scientific bodies, including the National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. Founded in 2013, Abivax S.A. maintains its headquarters in Paris, France.
OrganisationAbivax SA Sponsored ADR
Headquarters7-11 Boulevard Haussmann, Paris, IF, 75009, FR
IndustryBiotechnology
CEOMarc de Garidel

Key Management of Abivax SA Sponsored ADR

Name

Title

Mr. Timothy P. Kelly M.B.A.

Chief Technical Officer

Mr. Patrick Malloy

Senior VP & Head of Investor Relations

Ms. Ida Hatoum

Chief People & Compliance Officer

Mr. James Berger

Global Head of Marketing

Mr. Pierre Courteille M.B.A.

Chief Business Officer

Mr. Marc M. P. de Garidel M.B.A.

CEO & Director

Mr. Didier Blondel

EVP, CFO & Board Secretary

FAQs

What is Abivax SA Sponsored ADR share price today?

Abivax SA Sponsored ADR share price today is $86.59 as on at the close of the market. Abivax SA Sponsored ADR share today touched a day high of $88.80 and a low of $85.81.

What is the 52 week high and 52 week low for Abivax SA Sponsored ADR share?

Abivax SA Sponsored ADR share touched a 52 week high of $148.83 on and a 52 week low of $69.81 on . Abivax SA Sponsored ADR stock price today i.e. is closed at $86.59,which is 41.82% down from its 52 week high and 24.04% up from its 52 week low.

What is Abivax SA Sponsored ADR's market capitalisation today?

Abivax SA Sponsored ADR market capitalisation is $0.01T as on .

How to invest in Abivax SA Sponsored ADR Stock (ABVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abivax SA Sponsored ADR on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Abivax SA Sponsored ADR Stock (ABVX) from India?

Indian investors can start investing in Abivax SA Sponsored ADR (ABVX) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Abivax SA Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Abivax SA Sponsored ADR share’s latest price of $86.59 as on October 31, 2026 at 8:46 am IST, you will get 0.1155 shares of Abivax SA Sponsored ADR. Learn more about fractional shares .